AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alz...
Related Keywords
Sweden , Swedish , Johan Sandin , Azita Rasti , Gunnar Nordvall , Veronica Lidell , Pontus Forsell , Head Of Discovery Research At Alzecure Pharma , Clinical Trials , Alzecure Pharma , Nasdaq First North Premier Growth Market , Nerve Growth Factor , Brain Derived Neurotrophic Factor ,
vimarsana.com © 2020. All Rights Reserved.